Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

Form 8 (OPD) - finnCap Group plc

1 Nov 2022 11:02

RNS Number : 9145E
Panmure Gordon Group Limited
01 November 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Panmure Gordon Group Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

finnCap Group plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

31 October 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

Panmure Gordon Group Limited

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 1p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

Nil

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

None

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

1 November 2022

Contact name:

Barry Wainwright

Telephone number:

020 7886 2500

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEBKDBKDBDDKDK
Date   Source Headline
27th May 20104:14 pmRNSNet Asset Value(s)
24th May 20104:00 pmRNSNet Asset Value(s)
30th Apr 20109:48 amRNSNet Asset Value(s)
23rd Apr 20104:12 pmRNSNet Asset Value(s)
25th Mar 20103:37 pmRNSNet Asset Value(s)
19th Mar 20105:01 pmRNSNet Asset Value(s)
25th Feb 20104:38 pmRNSStatement re Half Yearly Financial Statements
25th Feb 20103:24 pmRNSNet Asset Value(s)
19th Feb 20104:31 pmRNSNet Asset Value(s)
4th Feb 20104:30 pmRNSReplacement Net Asset Value(s)
28th Jan 20103:48 pmRNSNet Asset Value(s)
22nd Jan 20104:28 pmRNSNet Asset Value(s)
22nd Dec 20099:49 amRNSNet Asset Value(s)
16th Dec 20095:29 pmRNSAGM Statement
27th Nov 20099:56 amRNSNet Asset Value(s)
20th Nov 20099:24 amRNSNet Asset Value(s)
12th Nov 20099:32 amRNSDirector Declaration
9th Nov 20092:46 pmRNSStatement re. Harbinger Capital Partners
30th Oct 20095:10 pmRNSNet Asset Value(s)
22nd Oct 200910:55 amRNSNet Asset Value(s)
14th Oct 20093:10 pmRNSAnnual Financial Report
12th Oct 20099:53 amRNSFurther Information Re Reporting and Liquidity
5th Oct 200911:39 amRNSLetter to Investors Re: Reporting and Liquidity
24th Sep 20094:58 pmRNSNet Asset Value(s)
22nd Sep 20092:56 pmRNSNet Asset Value(s)
14th Sep 200912:01 pmRNSHolding(s) in Company
21st Aug 20095:56 pmRNSNet Asset Value(s)
18th Aug 20099:36 amRNSHolding(s) in Company
14th Aug 200910:37 amRNSHolding(s) in Company
7th Aug 200910:19 amRNSTender Offer update - Amended
29th Jul 20094:19 pmRNSReplacement - Tender Offer update
29th Jul 200912:30 pmRNSTender Offer update
28th Jul 20095:24 pmRNSVoting Rights and Capital
28th Jul 20095:24 pmRNSNet Asset Value(s)
28th Jul 20091:55 pmRNSHolding(s) in Company
24th Jul 200911:20 amRNSNet Asset Value(s)
16th Jul 20092:19 pmRNSHolding(s) in Company
15th Jul 20095:18 pmRNSReplacement Holding(s) in Company
8th Jul 20095:00 pmRNSHolding(s) in Company
6th Jul 20094:54 pmRNSHolding(s) in Company
26th Jun 20091:46 pmRNSNet Asset Value(s)
22nd Jun 20092:08 pmRNSTender Offer results
19th Jun 20092:21 pmRNSNet Asset Value(s)
5th Jun 20092:00 pmRNSHolding(s) in Company
3rd Jun 20093:58 pmRNSResult of EGM
29th May 20092:21 pmRNSNet Asset Value(s)
22nd May 200911:25 amRNSNet Asset Value(s)
21st May 20093:43 pmRNSHolding(s) in Company
11th May 20092:40 pmRNSInterim Management Statements - replacement
8th May 20093:31 pmRNSInterim Management Statement - replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.